Drug General Information (ID: DDIF0APSDW)
  Drug Name Pentostatin Drug Info Strontium chloride Sr-89 Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Therapeutic Radiopharmaceuticals
  Structure

 Mechanism of Pentostatin-Strontium chloride Sr-89 Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Pentostatin Strontium chloride Sr-89
      Mechanism Myelosuppressive effects Myelosuppressive effects
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Pentostatin and Strontium chloride Sr-89 

Recommended Action
      Management Patients should be monitored for excessive bone marrow suppression during treatment with strontium-89 chloride. Dose reductions of the other bone marrow depressants may be necessary. Patients should be advised to contact their physician if they develop signs and symptoms of myelosuppression such as pallor, dizziness, fatigue, lethargy, fainting, easy bruising or bleeding, or signs of infection such as fever, chills, sore throat, body aches, and other influenza-like symptoms.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Multum Information Services, Inc. Expert Review Panel.